John P A Ioannidis

InstitutionStanford University
AddressStanford
California
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 32 Covid-19 publications, with a maximum of 7 publications in October 2020
    All Publications
    Bar chart showing 801 publications over 20 distinct years, with a maximum of 72 publications in 2013
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ioannidis JPA. Benefit of COVID-19 vaccination accounting for potential risk compensation. NPJ Vaccines. 2021 Aug 11; 6(1):99. PMID: 34381059.
      Citations: 2     
    2. Villani L, Pastorino R, Ricciardi W, Ioannidis J, Boccia S. Inverse correlates of COVID-19 mortality across European countries during the first versus subsequent waves. BMJ Glob Health. 2021 08; 6(8). PMID: 34373260.
      Citations:    Translation:Humans
    3. Ioannidis JPA. Over- and under-estimation of COVID-19 deaths. Eur J Epidemiol. 2021 Jun; 36(6):581-588. PMID: 34322831.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    4. Janiaud P, Hemkens LG, Ioannidis JPA. Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently? Can J Cardiol. 2021 09; 37(9):1353-1364. PMID: 34077789.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    5. Bendavid E, Mulaney B, Sood N, Shah S, Bromley-Dulfano R, Lai C, Weissberg Z, Saavedra-Walker R, Tedrow J, Bogan A, Kupiec T, Eichner D, Gupta R, Ioannidis JPA, Bhattacharya J. COVID-19 antibody seroprevalence in Santa Clara County, California. Int J Epidemiol. 2021 05 17; 50(2):410-419. PMID: 33615345.
      Citations: 87     Fields:    Translation:Humans
    6. Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, et al. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 May 14; 12(1):3001. PMID: 33990619.
      Citations: 4     Fields:    
    7. Axfors C, Schmitt AM, Janiaud P, Van't Hooft J, Abd-Elsalam S, Abdo EF, Abella BS, Akram J, Amaravadi RK, Angus DC, Arabi YM, Azhar S, Baden LR, Baker AW, Belkhir L, Benfield T, Berrevoets MAH, Chen CP, Chen TC, Cheng SH, Cheng CY, Chung WS, Cohen YZ, Cowan LN, Dalgard O, de Almeida E Val FF, de Lacerda MVG, de Melo GC, Derde L, Dubee V, Elfakir A, Gordon AC, Hernandez-Cardenas CM, Hills T, Hoepelman AIM, Huang YW, Igau B, Jin R, Jurado-Camacho F, Khan KS, Kremsner PG, Kreuels B, Kuo CY, Le T, Lin YC, Lin WP, Lin TH, Lyngbakken MN, McArthur C, McVerry BJ, Meza-Meneses P, Monteiro WM, Morpeth SC, Mourad A, Mulligan MJ, Murthy S, Naggie S, Narayanasamy S, Nichol A, Novack LA, O'Brien SM, Okeke NL, et al. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021 04 15; 12(1):2349. PMID: 33859192.
      Citations: 29     Fields:    Translation:Humans
    8. Ioannidis JPA. Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations. Eur J Clin Invest. 2021 May; 51(5):e13554. PMID: 33768536.
      Citations: 7     Fields:    Translation:Humans
    9. Bendavid E, Oh C, Bhattacharya J, Ioannidis JPA. Authors Response to Letters to the editor regarding: 'Assessing mandatory stay- At- Home and business closure effects on the spread of COVID- 19'. Eur J Clin Invest. 2021 06; 51(6):e13553. PMID: 33756017.
      Citations: 1     Fields:    Translation:Humans
    10. Chin V, Ioannidis JPA, Tanner MA, Cripps S. Effect estimates of COVID-19 non-pharmaceutical interventions are non-robust and highly model-dependent. J Clin Epidemiol. 2021 08; 136:96-132. PMID: 33781862.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    11. Janiaud P, Axfors C, Schmitt AM, Gloy V, Ebrahimi F, Hepprich M, Smith ER, Haber NA, Khanna N, Moher D, Goodman SN, Ioannidis JPA, Hemkens LG. Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis. JAMA. 2021 03 23; 325(12):1185-1195. PMID: 33635310.
      Citations: 54     Fields:    Translation:Humans
    12. Janiaud P, Axfors C, Ioannidis JPA, Hemkens LG. Recruitment and Results Reporting of COVID-19 Randomized Clinical Trials Registered in the First 100 Days of the Pandemic. JAMA Netw Open. 2021 03 01; 4(3):e210330. PMID: 33646310.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    13. Nielsen MW, Stefanick ML, Peragine D, Neilands TB, Ioannidis JPA, Pilote L, Prochaska JJ, Cullen MR, Einstein G, Klinge I, LeBlanc H, Paik HY, Schiebinger L. Gender-related variables for health research. Biol Sex Differ. 2021 Feb 22; 12(1):23. PMID: 33618769.
      Citations: 6     Fields:    Translation:Humans
    14. Pilz S, Chakeri A, Ioannidis JP, Richter L, Theiler-Schwetz V, Trummer C, Krause R, Allerberger F. SARS-CoV-2 re-infection risk in Austria. Eur J Clin Invest. 2021 Apr; 51(4):e13520. PMID: 33583018.
      Citations: 21     Fields:    Translation:Humans
    15. Ioannidis JPA, Axfors C, Contopoulos-Ioannidis DG. Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities. Environ Res. 2021 04; 195:110856. PMID: 33581086.
      Citations: 27     Fields:    Translation:Humans
    16. Bendavid E, Oh C, Bhattacharya J, Ioannidis JPA. Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19. Eur J Clin Invest. 2021 Apr; 51(4):e13484. PMID: 33400268.
      Citations: 32     Fields:    Translation:HumansPHPublic Health
    17. Ioannidis JPA. Precision shielding for COVID-19: metrics of assessment and feasibility of deployment. BMJ Glob Health. 2021 01; 6(1). PMID: 33514595.
      Citations: 5     Translation:HumansPHPublic Health
    18. Cristea IA, Naudet F, Ioannidis JPA. Preserving equipoise and performing randomised trials for COVID-19 social distancing interventions. Epidemiol Psychiatr Sci. 2020 Oct 28; 29:e184. PMID: 33109299.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    19. Ioannidis JPA, Jha P. Does the COVID-19 pandemic provide an opportunity to eliminate the tobacco industry? Lancet Glob Health. 2021 01; 9(1):e12-e13. PMID: 33120026.
      Citations: 1     Fields:    Translation:Humans
    20. Ioannidis JP. Scientific petitions and open letters in the era of covid-19. BMJ. 2020 10 26; 371:m4048. PMID: 33106240.
      Citations: 2     Fields:    
    21. Ioannidis JPA. Global perspective of COVID-19 epidemiology for a full-cycle pandemic. Eur J Clin Invest. 2020 Dec; 50(12):e13423. PMID: 33026101.
      Citations: 31     Fields:    Translation:HumansPHPublic Health
    22. Ewers M, Ioannidis JPA, Plesnila N. Access to data from clinical trials in the COVID-19 crisis: open, flexible, and time-sensitive. J Clin Epidemiol. 2021 02; 130:143-146. PMID: 33068714.
      Citations: 4     Fields:    Translation:Humans
    23. Ioannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021 Jan 01; 99(1):19-33F. PMID: 33716331.
      Citations: 70     Fields:    Translation:Humans
    24. Citations: 16     Fields:    Translation:HumansCellsPHPublic Health
    25. Peirlinck M, Linka K, Sahli Costabal F, Bhattacharya J, Bendavid E, Ioannidis JPA, Kuhl E. Visualizing the invisible: The effect of asymptomatic transmission on the outbreak dynamics of COVID-19. Comput Methods Appl Mech Eng. 2020 Dec 01; 372:113410. PMID: 33518823.
      Citations: 7     
    26. Ioannidis JPA, Cripps S, Tanner MA. Forecasting for COVID-19 has failed. Int J Forecast. 2022 Apr-Jun; 38(2):423-438. PMID: 32863495.
      Citations: 52     
    27. Chin V, Samia NI, Marchant R, Rosen O, Ioannidis JPA, Tanner MA, Cripps S. A case study in model failure? COVID-19 daily deaths and ICU bed utilisation predictions in New York state. Eur J Epidemiol. 2020 Aug; 35(8):733-742. PMID: 32780189.
      Citations: 11     Fields:    Translation:HumansCellsPHPublic Health
    28. Ioannidis JPA, Axfors C, Contopoulos-Ioannidis DG. Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters. Environ Res. 2020 09; 188:109890. PMID: 32846654.
      Citations: 84     Fields:    Translation:HumansCellsPHPublic Health
    29. Boccia S, Ricciardi W, Ioannidis JPA. What Other Countries Can Learn From Italy During the COVID-19 Pandemic. JAMA Intern Med. 2020 Jul 01; 180(7):927-928. PMID: 32259190.
      Citations: 99     Fields:    Translation:HumansCellsPHPublic Health
    30. Melnick ER, Ioannidis JPA. Should governments continue lockdown to slow the spread of covid-19? BMJ. 2020 06 03; 369:m1924. PMID: 32493767.
      Citations: 24     Fields:    Translation:HumansPHPublic Health
    31. Ioannidis JPA. Coronavirus disease 2019: The harms of exaggerated information and non-evidence-based measures. Eur J Clin Invest. 2020 Apr; 50(4):e13222. PMID: 32191341.
      Citations: 78     Fields:    Translation:HumansCellsPHPublic Health
    32. Ioannidis JPA. Coronavirus disease 2019: the harms of exaggerated information and non-evidence-based measures. Eur J Clin Invest. 2020 Mar 23; e13223. PMID: 32202659.
      Citations: 23     Fields:    
    Ioannidis's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (486)
    Explore
    _
    Co-Authors (205)
    Explore
    _
    Similar People (60)
    Explore
    _